In 1999, the Rotterdam Study uncovered the strong association between diabetes and Alzheimer’s disease. In this landmark study carried out in the Netherlands, 6,370 elderly men and women were followed for an average of two years. In what was perhaps one of the first reports on this issue, they found ... continue reading
DENVER Alzheimer’s disease is the longest goodbye. Just ask Barry Petersen. Since 2005, he has dealt with the fading faculties of his wife, Jan, who was diagnosed with younger-onset Alzheimer’s when she was 55. She has spent the past two years in an assisted living facility in Denver.
Go here ... continue reading
March 18 (Bloomberg) — One of the most eagerly anticipated studies of a drug for Alzheimer’s disease may not yield results until 2012, two years later than had been forecast.
Continued here:
Alzheimer Drug Test ... continue reading
The field is abuzz with the word “prevention,” but how to pull off this vaunted goal? It’s been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer’s Institute. ... continue reading
New imaging technology suggests an experimental drug for Alzheimer’s reduces clumps of plaque in the brain by around 25 percent, lifting hopes for a medicine that disappointed in clinical tests two years ago.
Excerpt from:
Brain images ... continue reading